Transcriptomics

Dataset Information

0

PD-L1 expression and immune escape in melanoma resistance to MAPK inhibitors


ABSTRACT: Thirty-eight tumors from 17 patients treated with BRAF inhibitor (n=12) or combination BRAF/MEK inhibitors (n=5) with known PD-L1 expression were analyzed. RNA expression arrays were performed on all pre-treatment (PRE, n=17), early during treatment (EDT, n=8) and progression (PROG, n=13) biopsies. HLA-A/HLA-DPB1 expression was assessed by immunohistochemistry (IHC). Gene set enrichment analysis (GSEA) of PRE, EDT and PROG melanomas revealed that transcriptome signatures indicative of immune cell activation were strongly positively correlated with PD-L1 staining. In contrast, MAPK signaling and canonical Wnt/-ß-catenin activity were negatively associated with PD-L1 melanoma expression. The expression of PD-L1 and immune activation signatures did not simply reflect the degree or type of immune cell infiltration, and was not sufficient for tumor response to MAPK inhibition.

ORGANISM(S): Homo sapiens

PROVIDER: GSE99898 | GEO | 2017/07/01

SECONDARY ACCESSION(S): PRJNA389975

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2022-03-31 | MSV000089180 | MassIVE
2020-09-24 | GSE158403 | GEO
2014-02-19 | E-GEOD-50509 | biostudies-arrayexpress
| phs001469 | dbGaP
2014-02-19 | GSE50509 | GEO
2021-08-19 | GSE177901 | GEO
2021-08-19 | GSE177900 | GEO
| phs001464 | dbGaP
2014-12-12 | E-GEOD-64102 | biostudies-arrayexpress
2019-02-01 | GSE114403 | GEO